Navigation Links
World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition

izations the choice of outsourcing the entire process, or building their own asset catalogues online, with enhanced ease of use guided selling capabilities. Through DoveBid's online industry auction exchanges, their assets immediately become visible to millions of buyers worldwide. DoveBid markets, sells, and manages the entire payment process, and provides access to global resources without the listing fees associated with consumer oriented online auction sites. Participants may bid online, review detailed asset descriptions, equipment catalogs, and online bidding instructions at www.dovebid.com.

"With over ten million capital asset transactions, DoveBid is the standard for valuation, management and disposition of global capital assets. The DoveBid portfolio of professional services and powerful web solutions deliver quantifiable value from the shop floor to the top floor," said Brent Cohen, CEO, DoveBid, Inc.


About DoveBid
DoveBid, Inc. is the global leader in capital asset management and valuation services, helping companies identify, redeploy and dispose of surplus assets through privately negotiated sales, live and online auctions, and industry specific web exchanges supporting key verticals and market segments. The Company provides strategic insight and valuation services for financial reporting, tax, secured lending and planning purposes.

Headquartered in Los Angeles, California, USA, DoveBid has over 67 years of industrial capital asset experience with more than 40 locations in 16 countries. More information on DoveBid can be found at www.dovebid.com or by contacting the company directly at (800) 665-1042
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Preserve Samples for RNA Expression Microarrays RNAlater Around the World
2. RNAlater Around the World: The Art of Processing Difficult Samples
3. The Worlds Best DNase Improved TURBO DNA-free
4. RNase Activity in Mouse Tissue: Classification, Hierarchy, and Methods for Control
5. Advantages of Roche Applied Science amplification products
6. Tools for Proteomic Science II
7. Exploiting the Life Science Data Explosion to Speed New Drug Discovery
8. Automation of the Eppendorf Perfectprep BAC 96 DNA Kit on the Caliper Life Sciences Sciclone ALH 3000
9. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
10. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
11. National Instruments DIAdem -- Complete Your Technical Data Management Framework with Powerful Off-line Analysis, Visualization, and Report Generation
Post Your Comments:
(Date:7/24/2008)...wswire-FirstCall/ -- Hologic, Inc.,(Nasdaq: HOLX ... tender,offer by its direct wholly-owned subsidiar...of Third Wave Technologies, Inc. (Nasdaq: TWTI ) ...equent offering period expired at 12:00 midnight, ...he initial tender offer period expired,at 12:00 mi...
(Date:7/24/2008)...wswire/ -- Cara Therapeutics, Inc.,announced today... funding,to its original $24 million Series C fina...ed by new investor, Devon Park Bioventures, and in...revious investors participating,in the round inclu...ational,Corporation and Wistar Morris. In conjunct...
(Date:7/24/2008)...- United,Therapeutics Corpo...ll,release its 2008 second quarter financial resul... 2008., United Therapeutics will host a half-hour...0 a.m. Eastern Time. The teleconference is accessi...callers dialing,1-706-679-8129. A rebroadcast of t...
(Date:7/23/2008)... Original Warrant Amount by an Additional ...24 /- Cell Therapeutics, In...ingle institutional investor,has agreed to purchas...ble,Senior Notes due 2011, with a conversion price...roximately 28.2 million shares of common stock wit...
Breaking Biology Technology:Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 2Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 3Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 4Cara Therapeutics Secures $12.3 Million in Series C Extension Financing 2Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants 2Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants 3
...nformation officer and vice provost for informatio...on has been narrowed to three Midwestern finalist...nalists are Ronald D. Kraemer, deputy CIO and asso...mation Technology (DoIT); Kathy Pletcher, associat...Green Bay ; and Deanna M. Raineri, associate dean ...
...ow they view the Viasys Healthcare,s NeuroCare G... excited about the growth potential of the Fitchbu...ement between Cardinal Health and Viasys Healthcar... the NeuroCare Group, for $1.5 billion, pending ap..., ,In a conference call with investors, several to...
... Workforce Development will make $850,000 in stat...otes high-tech skills training. , ,The funding, pa...e, will support the Emerging Industries Skills Par...between businesses and schools so that current and...market. , ,Grants will be offered to businesses, i...
...from the term cloning, even with the controversial...lieves in time the technique he developed to creat... in the development of human therapies, just as hu... biologist with the Scottish Center for Regenerat...in Madison to lecture on the science of that cloni...
Other Biology Technology:Cardinal Health likes growth potential of Viasys NeuroCare Group 2Cardinal Health likes growth potential of Viasys NeuroCare Group 3Biologist who cloned Dolly the sheep believes therapeutic cloning will gain acceptance 2Biologist who cloned Dolly the sheep believes therapeutic cloning will gain acceptance 3Biologist who cloned Dolly the sheep believes therapeutic cloning will gain acceptance 4
(Date:7/24/2008)...omise to make it easier for people with impaired v...harper distance vision. Schepens Eye Research Inst...innovative glasses over earlier devices in an arti... Biomedical Optics , mailed in print form to subs...ral advantages," says the inventor of the glasses,...
(Date:7/24/2008)...e University College of Medicine, Hershey, Pennsyl...od, a clinically important immune response modifie... dependent on the Opioid Growth Factor (OGF)-OGF r...y, reported in the August 08 issue of Experimenta...o a widely used drug that may lead to development ...
(Date:7/24/2008)...8) A multi-institutional team of researchers, inc...edical School, have developed a powerful tool for ...ill allow researchers to generate synthetic enzyme... inactivation or repair. , The potential for disc...f the Arnold and Mabel Beckman Center for Transpos...
(Date:7/24/2008)... is currently burning through a study area where p...ears ago. Managers used data and analysis from the...the planning, analysis, and implementation of trea...ive., The Gotchen LSR, lies on the east slope of... 15,000 acres of the Mount Adams Ranger District o...
Breaking Biology News(10 mins):Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Consortium develops new method to manipulate genetic material 2Landscape study may offer solutions for fire managers 2Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint 1363 1Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint 1363 2Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint 1363 3UT Southwestern plastic surgeons deploy new carbon dioxide based fractional laser 11748 1UT Southwestern plastic surgeons deploy new carbon dioxide based fractional laser 11748 2UT Southwestern plastic surgeons deploy new carbon dioxide based fractional laser 11748 3Cigarette after Valentine snuggle deadlier for some 2187 1Cigarette after Valentine snuggle deadlier for some 2187 2Cigarette after Valentine snuggle deadlier for some 2187 3Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 1Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 2Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 3Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 4Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 5Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 6
...mpoo to paints and varnishes can create self-sanit...public buildings that continue killing germs for m...state consortium of high school students and retir...s.com, 10 students from New York, Texas and Virgin...d railroader from Virginia to report their researc...
...d" on the international deep sea floor ?need prote...ns a new report from the Japan-based United Nation...AS). , Increasingly recognized as important to hum... deep sea resources are now more accessible and vu...ploration technology, the report says. , Known as...
...lts more accurate than PSA , Researchers at the U...have identified a panel of 22 biomarkers that toge...e cancer than the current prostate specific antige...22 issue of the New England Journal of Medicine. ,...31 prostate cancer patients prior to surgery, and ...
...g been thought to be important only to translate a...horses. But new evidence shows that tiny bits of R... roles in normal biology and in the development of... that production of these tiny RNAs, known as micr... and in certain tissues, but no one had been able ...
Other Biology News:Shampoo detergent added to paint makes surfaces self-sterilizing 2Clear rules needed to govern deep sea bioprospecting: UNU 2Clear rules needed to govern deep sea bioprospecting: UNU 3Clear rules needed to govern deep sea bioprospecting: UNU 4Clear rules needed to govern deep sea bioprospecting: UNU 5U-M researchers identify new blood test for prostate cancer 2U-M researchers identify new blood test for prostate cancer 3Once given 'no respect,' cells' tiny RNAS take driver's seat 2Once given 'no respect,' cells' tiny RNAS take driver's seat 3
Experion Pro260 chips are the microfluidic chips used to perform protein analysis with the Experion automated electrophoresis system. Each chip has the capacity to run 10 protein samples. Supplied as
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms.
... reliable automation for today's drug discovery, g...ies. Staccato Mini-Workstations offer the minimal ... handling and material management tasks. Staccato ...er's time proven CLARA™ assay development an...
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms.
Biology Products: